ADIPOQ and myeloid sarcoma: Previous cross-sectional studies have reported that hypoadiponectinemia is closely associated with MS and its components (12, 13); however, a meta-analysis has indicated that increased adiponectin level is an independent protector against the development of MS, especially in men (14).